This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Tejwani, G. A. Articles by Rattan, A. K. Search for Related Content PubMed PubMed Citation Articles by Tejwani, G. A. Articles by Rattan, A. K. Related Collections Pain Pharmacology

---

TECHNOLOGY, COMPUTING, AND SIMULATION

The Role of Spinal Opioid Receptors in Antinociceptive Effects Produced by Intrathecal Administration of Hydromorphone and Buprenorphine in the Rat

Department of Pharmacology, Ohio State University, College of Medicine and Public Health, Columbus

Address correspondence and reprint requests to Gopi A. Tejwani, PhD, Department of Pharmacology, Ohio State University, College of Medicine and Public Health, 5197 Graves Hall, 333 W 10th Ave., Columbus, OH 43210-1239. Address e-mail to Tejwani.1{at}osu.edu

The intrathecal administration of morphine has been the standard therapy to control long-term intractable pain. Recently, a panel of pain therapy experts suggested that because of the lack of efficacy or because of the side effects produced by morphine in some patients, other drugs, such as hydromorphone and buprenorphine, should be investigated for their analgesic properties. We designed this study to compare the efficacy of intrathecal hydromorphone and buprenorphine to suppress thermal nociception in male Sprague-Dawley rats. An additional objective was to understand whether hydromorphone and buprenorphine bind and act as agonists to µ-, -, and -spinal opioid receptors. Intrathecally-administered hydromorphone and buprenorphine produced a dose- and time-dependent increase in the tail-flick response latency in rats. The 50% effective dose value for the antinociceptive effect of buprenorphine and hydromorphone were 4 and 69.5 nmol/L, respectively. Both drugs act as agonists to µ-opioid receptors, as determined by their ability to displace [³H]-DAMGO from the spinal opioid receptors and by the ability of an opioid receptor antagonist, naloxone, to reverse their antinociceptive effects. Buprenorphine also has an agonistic effect on the -opioid receptors. For the first time, we report that intrathecal buprenorphine is approximately 17 times more effective than hydromorphone in inhibiting thermal pain, and buprenorphine produces its antinociceptive effect by acting as an agonist at both µ- and -spinal opioid receptors. Naloxone administered intrathecally was effective in preventing the antinociceptive effects of subsequent intrathecal injections of buprenorphine.

IMPLICATIONS:Hydromorphone and buprenorphine are two important drugs used for pain relief. We observed that intrathecal buprenorphine is 17 times more potent than hydromorphone to inhibit pain in rats. Both drugs exert their effects through specific spinal opioid receptors.

This article has been cited by other articles:

				D. R. H. Huntjens, M. Danhof, and O. E. Della Pasqua Pharmacokinetic pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors Rheumatology, July 1, 2005; 44(7): 846 - 859. [Abstract] [Full Text] [PDF]

				H. Mizoguchi, A. Spaulding, R. Leitermann, H.-E. Wu, H. Nagase, and L. F. Tseng Buprenorphine Blocks {epsilon}- and {micro}-Opioid Receptor-Mediated Antinociception in the Mouse J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 394 - 400. [Abstract] [Full Text] [PDF]